New Positions
1 managers initiated
Top five by reported value
Lipella Pharmaceuticals Inc. PNK:LIPO
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2024-09-30 · prior 2024-06-30.
1 new1 added4 reduced3 exited
Total Institutional Holders
5
as of 2024-09-30
Top Holder
VANGUARD GROUP INC
$16.3K
Largest QoQ Increase
HRT FINANCIAL LP
+17,619 sh
Largest QoQ Decrease
SABBY MANAGEMENT, LLC
-540,250 sh
New Positions(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| HRT FINANCIAL LP | 17,619 | +17,619 | $8 | +$8 | — |
Added To(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 47 | +1 | $22 | +$1 | 2.2% |
Reduced(4)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 34,520 | 0 | $16.3K | +$759 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 24,915 | -1,083 | $11.8K | -$352 | -4.2% |
| Tower Research Capital LLC (TRC) | 7,694 | -24 | $3.6K | +$159 | -0.3% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | 0 | $0 | $0 | — |
Sold Out(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 0 | -540,250 | $0 | -$243.1K | — |
| TWO SIGMA INVESTMENTS, LP | 0 | -12,984 | $0 | -$5.8K | — |
| UBS Group AG | 0 | -8,775 | $0 | -$3.9K | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2024-09-30.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| VANGUARD GROUP INC | 34,520 | $16.3K | 0 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 24,915 | $11.8K | -1,083 | -4.2% |
| Tower Research Capital LLC (TRC) | 7,694 | $3.6K | -24 | -0.3% |
| BANK OF AMERICA CORP /DE/ | 47 | $22 | +1 | 2.2% |
| HRT FINANCIAL LP | 17,619 | $8 | +17,619 | — |
New & Closed Positions this quarter
Closed Positions
3 managers exited
Top five by prior-quarter value
- SABBY MANAGEMENT, LLC$243.1K
- TWO SIGMA INVESTMENTS, LP$5.8K
- UBS Group AG$3.9K
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for LIPO against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.